Thalidomide has found a second life as an anti-cancer medication across a variety of cancers.
And in brain cancer trials, it has shown anti-tumor properties.
- Active Clinical Trials
As it is by prescription only, one would have to work with a doctor to take it.
We hope the studies provided here is enough information for someone to act upon; but, should you need more information, let us know and we'll try to help you find some.
None currently available
Title: Thalidomide as palliative treatment in patients with advanced secondary glioblastoma
Summary: In this study, Thalidomide was administered to patients experiencing recurrent disease and the authors retrospectively looked at the outcomes they experienced.
- Patients experienced longer survival than expected
- Patients experienced an improved sleep pattern
Title: Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastoma
Summary: This study tracked the administration of Thalidomide to patients experiencing recurrent disease after receiving traditional care.
- Stability of the tumor improved
- It warrants consideration for treatment of disease progression
- There were modest side effects